Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed. This update reflects administrative changes to the record history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the history, and removed the site-wide funding/operating-status notice along with the prior Revision: v3.4.1 entry. These changes relate to site-wide notices and version labeling rather than the core study content.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a government funding lapse notice and an operation status banner. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.7%

- Check48 days agoChange DetectedUI enhancements on the Record History page include a new 'Show glossary' option, color-coded highlights for changes (green for additions, red for deletions), and updated labels/notes such as 'No FEAR Act Data' and revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check62 days agoChange DetectedThe Record History now shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) has been removed, updating only the revision history metadata.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.